Follow Us On :
About Us
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
Bell, Sons & Co. (Druggists) Ltd.
Nova Pharmaceuticals Australasia Pty Ltd.
Relonchem Limited
Time Cap Labs, Inc.
R & D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Markets
USA
Europe
South East Asia
Africa
Russia & CIS
Latin America
Australasia
Manufacturing Facilities
Locations (Goa/ Southport - UK)
R & D
CRAMS
Out Licensing
Business Development
Investor Relations
General Information & Investor Contact
General Information
Investor Contact
Corporate Announcements
Finacial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
CSR Activities
Others Disclosures
Press Release
PD
Industry Overview
Health and Illness
Oncology And Critical Care
The Disorders Of The Mind And Nerves
Neurological Disorder
Mental Disorders
Skin Infections And Ulcers
Gastro - Intestinal Disorders (GI)
Cough Remedies
Women's Health
Bacterial Infections And Its Treatment
Blog
Careers
Overview
Values
Life at Marksans
Contact Us
Open Menu
Home
About Us
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
Bell, Sons & Co. (Druggists) Ltd.
Nova Pharmaceuticals Australasia Pty Ltd.
Relonchem Limited
Time Cap Labs, Inc.
R & D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Markets
USA
Europe
South East Asia
Africa
Russia & CIS
Latin America
Manufacturing Facilities
Locations (Goa/ Southport - UK)
R & D
CRAMS
Out Licensing
Business Development
Investor Relations
General Information & Investor Contact
General Information
Investor Contact
Corporate Announcements
Finacial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
CSR Activities
Others Disclosures
Press Release
PD
Industry Overview
Health and Illness
Oncology And Critical Care
The Disorders Of The Mind And Nerves
Neurological Disorder
Mental Disorders
Skin Infections And Ulcers
Gastro - Intestinal Disorders (GI)
Cough Remedies
Women's Health
Bacterial Infections And Its Treatment
Blog
Careers
Overview
Values
Life at Marksans
Contact Us
Site Map
Site Map
Home
Site Map
About Us
Company Profile
From the Chairman's Desk
Vision, Core Values
Milestones
Board of Directors
Management Profile
Mergers & Acquisitions
International Operations
Strategy
Subsidiaries
R & D Capabilities
Quality Policy
World Wide Operations
Formulation Business
Overview
Manufacturing Facilities
Markets
USA
Europe
South East Asia
Africa
Russia & CIS
Latin America
Australasia
R & D
CRAMS
Out Licensing
Business Development
Investor Relations
General Information & Investor Contact
General Information
Investor Contact
Corporate Announcements
Finacial Results
Quarterly Results
Annual Reports
Subsidiary Accounts
Investors Presentation
Compliances
Shareholding Pattern
Corporate Governance
Codes & Policies
Independent Directors
Investors Grievance Report
Shareholders Meeting
Unclaimed Dividend
CSR Activities
Others Disclosures
Press Release
PD
Industry Overview
Health and Illness
Oncology And Critical Care
The Disorders Of The Mind And Nerves
Skin Infections And Ulcers
Gastro - Intestinal Disorders (GI)
Cough Remedies
Women's Health
Bacterial Infections And Its Treatment
Blog
Careers
Overview
Values
Life at Marksans
Contact Us
© Copyright 2013 Marksans Pharma.
